Item 2.02. Results of Operations and Financial Condition.
On May 13, 2021, Phio Pharmaceuticals Corp. reported its financial results for
the period ended March 31, 2021. A copy of the press released is furnished as
Exhibit 99.1 to this Current Report on Form 8-K (the "Report").
The information in this Item 2.02 and attached as Exhibit 99.1 to this Report
will not be treated as "filed" for the purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to
the liabilities of that section. This information will not be incorporated by
reference into any filing under the Securities Act of 1933, as amended, or into
another filing under the Exchange Act, unless that filing expressly incorporates
this information by reference.
Item 9.01. Financial Statements and Exhibits.
Exhibit No. Description
99.1 Press release dated May 13, 2021.
© Edgar Online, source Glimpses